mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.09 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.1 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.1 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.1 |